Quantcast

Latest Personalized medicine Stories

2014-09-30 08:29:03

NEW YORK, Sept. 30, 2014 /PRNewswire/ -- Proteomics is a focus point for investment and collaboration, according to a new report from Kalorama Information. The healthcare market research publisher said that over 100 deals had occurred in proteomics in the past two years. The activity ranges from investments and IPOs, to agreements between private proteomic companies and academic institutions, to deals between pharma and biotech companies with novel proteomics innovator companies. Kalorama...

2014-09-29 08:31:27

DUBLIN, Ohio and CAMBRIDGE, Mass., Sept. 29, 2014 /PRNewswire/ -- Cardinal Health Specialty Solutions and KEW Group, Inc. (KEW), a privately held oncology services company, today announced an agreement for the two companies to make KEW's state-of-the-art diagnostic services available to Specialty Solutions' community oncology customers. KEW is a privately held oncology services company that is focused on revolutionizing cancer care by empowering all oncologists to access and apply genomic...

2014-09-24 16:24:38

LONDON, Sept. 24, 2014 /PRNewswire/ -- In vitro diagnostics are tests that diagnose and prevent diseases, conditions or infections. IVD tests are performed outside body in an artificial environment on samples such as blood, urine, tissue isolated from human body. IVD is classified into 3 types namely: clinical laboratory testing, near-patient testing, self-testing. IVD market is segmented by-techniques (including immunoassays, point of care, molecular diagnostics, hematology,...

2014-09-24 08:29:06

AIT, BioVendor and SCIENION signed cooperation agreement for early detection of colon cancer VIENNA, BRNO, Czech Republic and BERLIN, September 24, 2014 /PRNewswire/ -- The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers. Colon cancer is...

2014-09-23 23:08:14

Leading Oncology Reference Lab to Collaborate in Expanding Medivo’s Lab Value Exchange (LVX) Database of Anonymized Lab Test Results NEW YORK, N.Y. (PRWEB) September 23, 2014 Sept. 23, 2014 -- Medivo, Inc., a leader in lab data analytics, today announced that it has partnered with NeoGenomics Laboratories, a leading provider of cancer-focused genetic and molecular testing services, for a data analytics collaboration. This collaboration enables NeoGenomics to realize new value in its lab...

2014-09-23 23:02:21

OMICS Group International is elated to launch its 4th International Conference and Exhibition on Metabolomics and Systems Biology during April 27-29, 2015 at Philadelphia, USA, focusing on the theme “Metabolomics Technology and Omics Sciences - A Roadmap for Advanced Research Initiatives” Los Angeles, CA (PRWEB) September 23, 2014 Speaking on this occasion, Dr. Vladimir Bondarenko said “Organizing Committee for Metabolomics-2015 welcomes industrial and academic researchers to attend...

2014-09-23 08:30:02

CAMBRIDGE, Mass., Sept. 23, 2014 /PRNewswire/ -- GenoSpace, a precision medicine software company that has developed a comprehensive suite of tools to enable the broad use of genomic data in research and clinical care, today announced that it has been awarded Phase I of a Fast Track Small Business Innovation Research Grant (SBIR) from the National Institutes of Health (NIH) to enable enhanced data access and cohort construction for biorepositories. Logo -...

2014-09-19 04:21:35

DUBLIN, September 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qqjrnh/global_molecular) has announced the addition of the "Global Molecular Cytogenetics Market 2014-2018" [http://www.researchandmarkets.com/research/qqjrnh/global_molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular Cytogenetics involves the study of chromosomes using molecular biology to understand...

2014-09-18 08:30:46

DUBLIN, Sept. 18, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The global companion diagnostics market is expected to grow at a CAGR of 22.7% from 2014 to 2019. Factors such as rising need for personalized medicine in cancer treatment, growing...

2014-09-16 16:28:44

LONDON, Sept. 16, 2014 /PRNewswire/ -- This report analyzes the worldwide markets for Molecular Diagnostics in US$ Thousands by the following Applications: Infectious Disease Testing, Blood Screening, Cancer Screening, and Other Applications. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related